← Back to Search

High vs Low Intensity Treatment Strategies for Opioid Addiction (EXHITENTRE Trial)

N/A
Recruiting
Research Sponsored by Hennepin Healthcare Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Provide inpatient general medical care
Must not have
Have an existing, functioning HBOT program or be imminently starting an HBOT initiative
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 34 days following hospital discharge
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing two different strategies for implementing medication-based treatment for opioid addiction in community hospitals.

Who is the study for?
This trial is for community hospitals that want to start treating opioid use disorder (OUD) in hospitalized patients. Hospitals must be willing to adopt new treatment strategies, have staff trained, and work with a site champion. They should not already have an opioid treatment program or be a Veterans Affairs hospital.
What is being tested?
The study compares two methods of implementing hospital-based opioid use disorder treatments: one with low-intensity support and another with high-intensity support. It aims to see which strategy better supports the adoption of medication treatments for OUD in community hospitals.
What are the potential side effects?
Since this trial focuses on implementation strategies rather than direct patient interventions, it does not directly involve side effects related to medications or treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am receiving general medical care as a hospital inpatient.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am part of or about to start a hyperbaric oxygen therapy program.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~34 days following hospital discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and 34 days following hospital discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Engagement with MOUD

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High IntensityExperimental Treatment1 Intervention
MOUD training and support through the use of educational materials in addition to practice facilitation.
Group II: Low IntensityActive Control1 Intervention
MOUD training and support through the use of educational materials.

Find a Location

Who is running the clinical trial?

Hennepin Healthcare Research InstituteLead Sponsor
92 Previous Clinical Trials
77,169 Total Patients Enrolled
The Emmes Company, LLCIndustry Sponsor
147 Previous Clinical Trials
1,052,114 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,607 Previous Clinical Trials
3,329,791 Total Patients Enrolled

Media Library

High Intensity Clinical Trial Eligibility Overview. Trial Name: NCT04921787 — N/A
Substance Use Disorder Research Study Groups: Low Intensity, High Intensity
Substance Use Disorder Clinical Trial 2023: High Intensity Highlights & Side Effects. Trial Name: NCT04921787 — N/A
High Intensity 2023 Treatment Timeline for Medical Study. Trial Name: NCT04921787 — N/A
~5 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top